Pentosuria

Pentosuria, also known as essential pentosuria or L-xylulosuria, is a benign inborn error of metabolism characterized by the excessive excretion of the sugar L-xylulose in the urine. It is caused by a deficiency of the enzyme L-xylulose reductase (also called xylitol dehydrogenase), encoded by the DCXR gene, which plays a role in the glucuronic acid oxidation pathway (also known as the pentose phosphate pathway of uronic acid metabolism). Without this enzyme, L-xylulose accumulates and is excreted in the urine in amounts typically ranging from 1 to 4 grams per day. Pentosuria is an entirely benign condition and does not cause any clinical symptoms or health complications. Affected individuals are completely asymptomatic, and the condition has no impact on life expectancy or quality of life. The primary clinical significance of pentosuria lies in the fact that L-xylulose in the urine can produce a positive result on urine reducing substance tests (such as the Benedict's test or Clinitest), which may lead to a misdiagnosis of diabetes mellitus. However, glucose-specific tests (such as glucose oxidase-based dipsticks) will correctly show negative results, allowing differentiation from true glycosuria. Pentosuria is found almost exclusively in individuals of Ashkenazi Jewish descent, though rare cases have been reported in other populations. No treatment is required for this condition, as it is clinically harmless. The only management consideration is ensuring that affected individuals and their healthcare providers are aware of the diagnosis to avoid unnecessary investigations or misdiagnosis of diabetes. Genetic counseling may be offered to explain the benign nature and inheritance pattern of the condition.

Common questions about Pentosuria